Cornercap Investment Counsel Inc Kronos Bio, Inc. Transaction History

Cornercap Investment Counsel Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$0.73 - $1.38 $834 - $1,577	-1,143 Reduced 2.76%	40,208 $49,000
Q3 2023 Nov 13, 2023	BUY	$1.23 - $2.25 $692 - $1,266	563 Added 1.38%	41,351 $53,000
Q2 2023 Aug 11, 2023	BUY	$1.24 - $1.92 $8,036 - $12,443	6,481 Added 18.89%	40,788 $70,000
Q1 2023 May 11, 2023	BUY	$1.34 - $2.62 $6,740 - $13,178	5,030 Added 17.18%	34,307 $50,000
Q2 2022 Aug 15, 2022	BUY	$3.12 - $7.52 $91,344 - $220,163	29,277 New	29,277 $107,000

19.8M

9.3K

100

Ticker KRON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,769,100
Market Cap $53.9M
Description
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...

Get notified when there are updates to the investment portfolio of Cornercap Investment Counsel Inc, based on Form 13F filings with the SEC.

Stay updated on Cornercap Investment Counsel Inc with notifications on news.